Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SCOT Registry: Small Cell Lung Cancer Treatment and Outcome

NCT00997061 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00997061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00997061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SCOT Registry: Small Cell Lung Cancer Treatment and Outcome
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
February 29, 2012
Enrollment
500 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, small cell